| Phase 1/2 | 1 | |
| Phase 2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT03837483 | A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in… | Wiskott-Aldrich Syndrome | Active, Not Recruiting | 2025-09-29 |
| Phase 2 | ||||
| NCT07680803 | Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia | Transfusion-dependent Beta-Thalassemia | Recruiting | 2026-07-27 |
| Phase 1/2 | ||||
| NCT07665021 | Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO) | Osteopetrosis | Recruiting | 2026-06-24 |
| Not specified | ||||
| NCT03478670 | Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined… | Immunologic Deficiency Syndromes | Enrolling by Invitation | 2026-05-22 |
Thalassemia (1)